14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Agios Pharmaceuticals Stock Forecast

NASDAQ:AGIO BUY SELL

$21.09 (-0.0474%)

Volume: 557.742k

Closed: May 23, 2022

Hollow Logo Score: -1.957

Agios Pharmaceuticals Stock Forecast

BUY SELL NASDAQ:AGIO
$21.09 (-0.0474%)

Volume: 557.742k

Closed: May 23, 2022

Score Hollow Logo -1.957

Agios Pharmaceuticals Stock Forecast NASDAQ:AGIO

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-17 56.47% SVB Leerink $30.00 $33.00 Maintains Market Perform
2022-03-07 9.06% Goldman Sachs $37.00 $23.00 Maintains Sell
2022-03-03 355.19% HC Wainwright & Co. $98.00 $96.00 Maintains Buy
2022-02-25 217.69% RBC Capital $61.00 $67.00 Maintains Outperform
2022-02-24 355.19% HC Wainwright & Co. $98.00 $96.00 Maintains Buy
2022-02-22 42.25% SVB Leerink $32.00 $30.00 Maintains Market Perform
2022-02-18 364.68% HC Wainwright & Co. $95.00 $98.00 Maintains Buy
2022-02-16 108.63% Canaccord Genuity $52.00 $44.00 Maintains Buy
2021-12-03 156.05% B of A Securities $54.00 Initiates Coverage On Buy
2021-11-18 99.15% SVB Leerink $50.00 $42.00 Maintains Market Perform
2021-11-04 350.45% HC Wainwright & Co. $93.00 $95.00 Maintains Buy
2021-07-30 340.97% HC Wainwright & Co. $88.00 $93.00 Maintains Buy
2021-07-30 84.92% Goldman Sachs $58.00 $39.00 Downgrades Neutral Sell
2021-07-01 - Raymond James - Initiates Coverage On Market Perform
2021-06-10 317.26% HC Wainwright & Co. $88.00 Initiates Coverage On Buy
2021-04-30 208.2% Canaccord Genuity $57.00 $65.00 Maintains Buy
2021-03-01 156.05% JP Morgan $54.00 Downgrades Overweight Neutral
2021-02-26 137.08% SVB Leerink $55.00 $50.00 Downgrades Outperform Market Perform
2021-01-27 160.79% SVB Leerink $51.00 $55.00 Maintains Outperform
2020-12-28 170.27% Canaccord Genuity $70.00 $57.00 Maintains Buy
2020-12-09 189.24% SVB Leerink $67.00 $61.00 Maintains Outperform
2020-10-22 118.11% Barclays $46.00 Upgrades Equal-Weight Overweight
2020-10-19 231.91% Canaccord Genuity $72.00 $70.00 Maintains Buy
2020-10-19 246.14% Piper Sandler $80.00 $73.00 Maintains Overweight
2020-10-19 217.69% SVB Leerink $72.00 $67.00 Maintains Outperform
2020-10-19 227.17% Needham $71.00 $69.00 Maintains Buy
2020-07-31 241.39% Cantor Fitzgerald $70.00 $72.00 Maintains Overweight
2020-06-15 241.39% SVB Leerink $70.00 $72.00 Maintains Outperform
2020-06-15 255.62% Citigroup $64.00 $75.00 Maintains Buy
2020-05-04 288.81% JP Morgan $72.00 $82.00 Maintains Overweight
2020-03-04 137.08% Barclays $50.00 Initiates Coverage On Equal-Weight
2020-02-14 231.91% Cantor Fitzgerald $64.00 $70.00 Reiterates Overweight
2019-12-09 132.34% BMO Capital $45.00 $49.00 Maintains Outperform
2019-12-04 222.43% JP Morgan $80.00 $68.00 Maintains Overweight
2019-11-26 203.46% Cantor Fitzgerald $64.00 Initiates Coverage On Overweight
2019-11-05 203.46% Citigroup $80.00 $64.00 Maintains Buy
2019-09-23 - Guggenheim - Upgrades Neutral Buy
2019-09-12 113.37% BMO Capital $45.00 Initiates Coverage On Outperform
2019-05-23 160.79% Goldman Sachs $55.00 Assumes Neutral

AGIO Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -31.43% during the next 3 months and, with a 90% probability hold a price between $12.71 and $17.16 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-25 $18.35 $21.60 $24.84
2022-05-26 $18.16 $21.41 $24.65
2022-05-27 $17.98 $21.22 $24.46
2022-05-31 $17.79 $21.03 $24.27
2022-06-01 $17.60 $20.84 $24.09
2022-06-02 $17.41 $20.65 $23.90
2022-06-03 $17.22 $20.47 $23.71
2022-06-06 $17.04 $20.28 $23.52
2022-06-07 $16.85 $20.09 $23.33
2022-06-08 $16.66 $19.90 $23.15
2022-06-09 $16.47 $19.71 $22.96
2022-06-10 $16.28 $19.53 $22.77
2022-06-13 $16.10 $19.34 $22.58
2022-06-14 $15.91 $19.15 $22.39
2022-06-15 $15.72 $18.96 $22.21
2022-06-16 $15.53 $18.77 $22.02
2022-06-17 $15.34 $18.59 $21.83
2022-06-21 $15.15 $18.40 $21.64
2022-06-22 $14.97 $18.21 $21.45
2022-06-23 $14.78 $18.02 $21.27
2022-06-24 $14.59 $17.83 $21.08
2022-06-27 $14.40 $17.65 $20.89
2022-06-28 $14.21 $17.46 $20.70
2022-06-29 $14.03 $17.27 $20.51
2022-06-30 $13.84 $17.08 $20.33
2022-07-01 $13.65 $16.89 $20.14
2022-07-05 $13.46 $16.71 $19.95
2022-07-06 $13.27 $16.52 $19.76
2022-07-07 $13.09 $16.33 $19.57
2022-07-08 $12.90 $16.14 $19.39

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines for the treatment of cancer and rare genetic metabolic disorders in the United States. The company’s product candidates include AG-221, an potent inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein that is in Phase I/II, Phase Ib combination, and Phase III IDHENTIFY clinical trials for the treatment of hematologic maligna... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT